TRP_1170x120_3-8-19

Issue 08-12-2019

Cannabis-based product rules continue to vary

Cannabis-based product rules continue to vary

There is a growing public focus on the potential for legitimate pharmacological uses of cannabis. Much of this focus has been directed toward medical marijuana — the use of marijuana in plant form or its basic extracts. Although some states have legalized its use, the Food and Drug Administration has not approved marijuana in plant

Pharmacies excel as resource for specialty patients

Pharmacies excel as resource for specialty patients

As specialty drugs grow in importance and prominence, this is an ideal moment to consider the essential and evolving roles retail pharmacies play in this significant health care category. Whether patients are using specialty treatments to cope with a rare cancer or some of the most common chronic illnesses, including psoriasis, rheumatoid arthritis (RA), Crohn’s

Patient data: seeking to balance access and security

Patient data: seeking to balance access and security

The continued digitization of electronic health records (EHRs) and growth in the number of wearables and Internet of Things (IoT) devices are rapidly expanding the volume of patient data. This increased digitalization offers patients more access to their health histories and the ability to track and take active responsibility for their health. EHRs also hold

Prescription-to-O-T-C switches are a win all around

Prescription-to-O-T-C switches are a win all around

Now is the time for Food and Drug Administration reforms designed to dramatically increase the number of prescription-to-O-T-C switches in the U.S. At a time when both political parties are pushing for transparency and pricing reform, the opportunity to align multiple agendas that benefit consumers, retail pharmacies and the health care system overall is too

Reaching out to consumers to improve their health

Reaching out to consumers to improve their health

In 2018, five national pharmacy associations and a growing number of state associations launched Pharmacists for Healthier Lives, (PfHL), a public education campaign targeting influential groups of consumers and health professionals. The campaign was described in the February 8, 2019, issue of Chain Drug Review. This article drills deeper into the questions of why such

Delivering improved outcomes with central fill technology

Delivering improved outcomes with central fill technology

An aging population, rising drug costs, DIR fees, value-based insurance plans, disruptive new market players and new specialty drugs are just a few of the rapidly evolving trends that continue to put pressure on the industry and pull pharmacy staff in directions that take time away from consultative patient care. Through all the change, the

Technology: Advancing the practice of pharmacy

Technology: Advancing the practice of pharmacy

It’s no secret that community pharmacy is facing a period of tremendous challenge. With diminishing reimbursement, the continued prevalence and negative impact of DIR (direct and indirect remuneration) fees, and market pressures born by the vertical integration of health care, there may have never been a time as challenging as the present for pharmacy. However,

Three critical issues to focus on in Boston

Three critical issues to focus on in Boston

As stakeholders in chain pharmacy gather this month for the National Association of Chain Drug Stores’ Total Store Expo in Boston, the industry confronts a host of important issues — legal proceedings in which it is asserted that retailers and drug wholesalers bear at least some responsibility for the ongoing opioid epidemic; the emergence of

Women executives excel as well as succeed

Women executives excel as well as succeed

A recent event affirmed a retailing revolution. Representatives from some of America’s leading mass market retailers gathered in New York City to accept awards for the contributions they have made to their companies and the retailing community. What was remarkable — or perhaps not so — was that these award winners were all women. They

Best ideas aren’t always (or often) from Washington

Best ideas aren’t always (or often) from Washington

Earlier this spring, the National Pharmaceutical Council (NPC) partnered with the Healthcare Leadership Council to hold town hall meetings in Raleigh, N.C., and Nashville. We asked health care leaders in those communities what really matters to them. Participants focused on the top of the health care funnel: prevention. Many thoughtful participants in those rooms felt